BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10639453)

  • 1. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.
    Goldman DL; Lee SC; Mednick AJ; Montella L; Casadevall A
    Infect Immun; 2000 Feb; 68(2):832-8. PubMed ID: 10639453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide.
    Rivera J; Mukherjee J; Weiss LM; Casadevall A
    J Immunol; 2002 Apr; 168(7):3419-27. PubMed ID: 11907100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas.
    Goldman D; Cho Y; Zhao M; Casadevall A; Lee SC
    Am J Pathol; 1996 Apr; 148(4):1275-82. PubMed ID: 8644868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.
    Kakeya H; Udono H; Maesaki S; Sasaki E; Kawamura S; Hossain MA; Yamamoto Y; Sawai T; Fukuda M; Mitsutake K; Miyazaki Y; Tomono K; Tashiro T; Nakayama E; Kohno S
    Clin Exp Immunol; 1999 Mar; 115(3):485-90. PubMed ID: 10193422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
    Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.
    Goldman D; Lee SC; Casadevall A
    Infect Immun; 1994 Nov; 62(11):4755-61. PubMed ID: 7927751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual role for TGF-beta1 in the control and persistence of fungal pneumonia.
    Shao X; Rivera J; Niang R; Casadevall A; Goldman DL
    J Immunol; 2005 Nov; 175(10):6757-63. PubMed ID: 16272332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.
    He W; Casadevall A; Lee SC; Goldman DL
    Infect Immun; 2003 Feb; 71(2):930-6. PubMed ID: 12540575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis.
    Arora S; Hernandez Y; Erb-Downward JR; McDonald RA; Toews GB; Huffnagle GB
    J Immunol; 2005 May; 174(10):6346-56. PubMed ID: 15879135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
    Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
    Wormley FL; Cox GM; Perfect JR
    Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans meningitis in the rat.
    Goldman DL; Casadevall A; Cho Y; Lee SC
    Lab Invest; 1996 Dec; 75(6):759-70. PubMed ID: 8973471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
    Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
    PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary cryptococcosis in the rat.
    Graybill JR; Ahrens J; Nealon T; Paque R
    Am Rev Respir Dis; 1983 May; 127(5):636-40. PubMed ID: 6342482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans.
    Heung LJ; Hohl TM
    Infect Immun; 2016 Jun; 84(6):1879-86. PubMed ID: 27068093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to Cryptococcus neoformans proteins in rodents and humans.
    Chen LC; Goldman DL; Doering TL; Pirofski La; Casadevall A
    Infect Immun; 1999 May; 67(5):2218-24. PubMed ID: 10225877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.
    Arora S; Olszewski MA; Tsang TM; McDonald RA; Toews GB; Huffnagle GB
    Infect Immun; 2011 May; 79(5):1915-26. PubMed ID: 21383052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptococcus neoformans infection can elicit protective antibodies in mice.
    Mukherjee J; Scharff MD; Casadevall A
    Can J Microbiol; 1994 Oct; 40(10):888-92. PubMed ID: 8000967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcus neoformans Evades Pulmonary Immunity by Modulating Xylose Precursor Transport.
    Li LX; Hole CR; Rangel-Moreno J; Khader SA; Doering TL
    Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32423915
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
    Hardison SE; Wozniak KL; Kolls JK; Wormley FL
    Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.